Covid-19 Studies

Spectroscopic investigation and structural simulation in human serum albumin with hydroxychloroquine/Silybum marianum and a possible potential COVID-19 drug candidate.

Tossers studied binding between HCQ/SM and HSA, inducing conformational changes, with potential therapeutic relevance for COVID-19 due to strong interaction with virus proteases. Valuable insights for pharmaceutical and biological properties.

Tekyeh MSH et al (2024).
Arch Pharm (Weinheim).
PubMed:
38644340

The effects of opium consumption on severity of disease on hospitalized COVID-19 patients in East of Iran, a prospective cohort study.

Opium use impacts COVID-19 severity, with higher hypertension and urea levels, lower lymphocytes, and increased risk of hospitalization and mortality. You should care because opium use affects the outcome of COVID-19 patients.

Pagheh AS et al (2024).
Transl Clin Pharmacol.
PubMed:
38586125

Screening for Active Compounds of Acorus calamus against SARS-CoV-2 Viral Protease and Mechanism Prediction.

Researchers found potential antiviral compounds from traditional Chinese medicine that showed inhibitory effects on SARS-CoV-2 proteases. Compound 1,5,7-guaiane-4,10-diol-6-one demonstrated the best inhibitory activity. These findings could lead to the development of new antiviral treatments for COVID-19.

Huang Y et al (2024).
Pharmaceuticals (Basel).
PubMed:
38543111

Predicting anti-COVID-19 potential: in silico analysis of Mauritine compound from Ziziphus-spina christi as a promising papain-like protease (PLpro) inhibitor.

Researchers studied the antiviral effects of the plant compound Mauritine on COVID-19 protease. Mauritine-A and Mauritine-C show promise with strong binding affinity and stability. This could lead to potential COVID-19 treatments.

Fakih TM et al (2024).
J Biomol Struct Dyn.
PubMed:
38529845

Potential Antiviral Effect of Korean Forest Wild Mushrooms against Feline Coronavirus (FCoV).

Wild forest mushrooms such as Pleurotus ostreatus and Phallus luteus show promise as antiviral agents against coronaviruses, including SARS-CoV-2. Controlling CoV infections in animals is crucial for preventing human outbreaks. This research suggests a potential new avenue for coronavirus treatment using natural resources.

Ryoo R, Lee H and Park Y (2024).
Int J Med Mushrooms.
PubMed:
38523445

Antibacterial and anti-coronavirus investigation of selected Senegalese plant species according to an ethnobotanical survey.

In Senegal, local medicinal plants from families Combretaceae, Fabaceae, Myrtaceae, and Rubiaceae are commonly used to treat respiratory infections. Understanding their effectiveness can inform treatment strategies in the region.

Ba A et al (2024).
J Ethnopharmacol.
PubMed:
38521430

Aesculus hippocastanum extract and the main bioactive constituent β-escin as antivirals agents against coronaviruses, including SARS-CoV-2.

Summary: β-escin from Aesculus hippocastanum has anti-inflammatory effects and affects NF-κB signaling. It shows promising broad-spectrum antiviral activity against coronaviruses including SARS-CoV-2, with potential as a therapeutic option for respiratory virus outbreaks.

Peñaranda Figueredo FA et al (2024).
Sci Rep.
PubMed:
38494515

Eucalyptus Oils Phytochemical Composition in Correlation with Their Newly Explored Anti-SARS-CoV-2 Potential: in Vitro and in Silico Approaches.

"Eucalyptus citriodora essential oil shows strong potential against SARS-CoV-2. Globulol is a key compound. In silico and in vitro studies support its effectiveness. Promising for future COVID-19 research."

El-Shiekh RA et al (2024).
Plant Foods Hum Nutr.
PubMed:
38492174